Showing 9201-9210 of 19239 results for "".
- The Impact of AI on Learners' Self-Efficacy: Insights for Clinical Practicehttps://reachmd.com/news/the-impact-of-ai-on-learners-self-efficacy-insights-for-clinical-practice/2485442/A meta-analysis of 23 studies found a medium, statistically significant aggregate effect of AI interventions on learner self-efficacy (Hedges' g = 0.758), supporting the
- Innovations in Pulmonary Drug Delivery: The Promise of Novel Inhalation Solutionshttps://reachmd.com/news/innovations-in-pulmonary-drug-delivery-the-promise-of-novel-inhalation-solutions/2485445/Pirfenidone inhalation solution is a low‑irritation aerosol designed for direct lung delivery, aiming to preserve pulmonary antifibrotic efficacy while reducing systemic and hepatic exposure.
- Analyzing Lymphadenectomy Morbidity in Stage III Melanoma: A Single-Center Perspectivehttps://reachmd.com/news/analyzing-lymphadenectomy-morbidity-in-stage-iii-melanoma-a-single-center-perspective/2485433/A single-center cohort of 185 patients found that therapeutic lymphadenectomy for stage III melanoma carries basin-specific morbidity, with substantially higher groin (ingu
- Obesity and Dementia: Unraveling the Direct Link and Its Clinical Implicationshttps://reachmd.com/news/obesity-and-dementia-unraveling-the-direct-link-and-its-clinical-implications/2485423/A recent study finds that higher body mass index and elevated blood pressure are direct causal contributors to dementia, reframin
- Digital Health Integration in Schools: Advancing Food Allergy Managementhttps://reachmd.com/news/digital-health-integration-in-schools-advancing-food-allergy-management/2485425/A recent systematic review finds school-delivered digital health interventions improve staff preparedness, family confidence, and student inclusion for food allergy manag
- Impact of BMI on Psoriasis Severity and Systemic Inflammation: Clinical Implicationshttps://reachmd.com/news/impact-of-bmi-on-psoriasis-severity-and-systemic-inflammation-clinical-implications/2485437/A pooled analysis of 18 randomized ixekizumab trials shows higher BMI is associated with
- Podium Introduces Artificial Intelligence Operating System Designed for Aesthetic Practiceshttps://reachmd.com/news/podium-introduces-artificial-intelligence-operating-system-designed-for-aesthetic-practices/2485420/Podium has announced the launch of an artificial intelligence (AI)–driven operating system designed specifically for aesthetic practices, positioning the platform as a unified alternative to the fragmented software ecosystems common in cosmetic dermatology practices. The company describes the pro
- Stress Mindset and Psychological Adjustment: New Insights from Recent Studieshttps://reachmd.com/news/stress-mindset-and-psychological-adjustment-new-insights-from-recent-studies/2485405/A recent study of 709 adults found that psychological adjustment predicts tolerance for psychological pain, with perceived stress and stress mindset appearing as serial mediators. The inve
- Rising Glaucoma Burden and Innovative Treatment Horizons in the UKhttps://reachmd.com/news/rising-glaucoma-burden-and-innovative-treatment-horizons-in-the-uk/2485412/A recent national projection analysis indicates glaucoma prevalence in people aged over 40 will rise sharply, creating substantial long‑term service demand. The number of peo
- Low-Dose Minocycline Superior in Treating Inflammatory Rosaceahttps://reachmd.com/news/low-dose-minocycline-dfd-29-superior-in-treating-inflammatory-rosacea/2485398/New data presented at 2026 Winter Clinical Hawaii showed DFD-29, a modified low-dose oral minocycline 40 mg, significantly outperformed both placebo and doxycycline 40 mg in the treatment of inflammatory lesions in patients with moderate-to-severe rosacea.